These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7386491)

  • 1. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of multiple bolus loading of intravenous disopyramide.
    Simpson RJ; Foster JR; Benge C; Baker S; Gettes LS
    Am Heart J; 1983 Sep; 106(3):505-8. PubMed ID: 6881023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy.
    Kimball BP; Bui S; Wigle ED
    Am Heart J; 1993 Jun; 125(6):1691-7. PubMed ID: 8498312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral disopyramide therapy on left ventricular function.
    Greene AC; Iskandrian AS; Hakki AH; Kane SA; Segal BL
    Chest; 1983 Mar; 83(3):480-4. PubMed ID: 6825481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous disopyramide in myocardial infarction: a haemodynamic study.
    Marrott PK; Nairn PL; Hill PD; Turner G; Sharman J
    N Z Med J; 1983 Jan; 96(723):4-7. PubMed ID: 6571755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic effects of disopyramide in patients after open-heart surgery.
    Naqvi N; Thompson DS; Morgan WE; Williams BT; Coltart DJ
    Br Heart J; 1979 Nov; 42(5):587-94. PubMed ID: 316334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disopyramide in hypertrophic cardiomyopathy. I. Hemodynamic assessment after intravenous administration.
    Pollick C; Kimball B; Henderson M; Wigle ED
    Am J Cardiol; 1988 Dec; 62(17):1248-51. PubMed ID: 3195486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antiarrhythmic effect of intravenous disopyramide in an open study.
    Tonkin AM; Heddle WF; Bett JH; Kemp RJ; Donnelly GL; Nelson GI; Manolas E; Sloman JG
    Aust N Z J Med; 1982 Aug; 12(4):271-5. PubMed ID: 6958238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of disopyramide of left ventricular function: an echocardiographic study of the extent and time course (author's transl)].
    Angermann C; Autenrieth G
    Klin Wochenschr; 1981 Jul; 59(14):803-11. PubMed ID: 7265814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intravenous disopyramide on myocardial function in patients with different degrees of cardiac failure.
    Chiariello M; Ferro G; Santinelli V; Tari MG; Spinelli L; Condorelli M
    Jpn Heart J; 1980 Mar; 21(2):197-203. PubMed ID: 7373860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of disopyramide using a new model of intravenous administration.
    Bonde J; Pedersen LE; Angelo HR; Svendsen TL; Trap-Jensen J; Graudal NA; Kampmann JP
    Pharmacol Toxicol; 1987 Mar; 60(3):179-83. PubMed ID: 3588512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.